Mednet Logo
CommunityRadiation Oncology

Are the results of CONKO-007 changing practice for the management of pancreatic cancer?

Specifically, have the results influenced the management of upfront unresectable patients who are fit and motivated for curative-intent treatment? CONKO-007
1 Answer
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Memorial Sloan-Kettering Cancer Center
Answered on

The results of CONKO-007 are exactly as expected. The clinically relevant endpoint of OS was not improved with the addition of chemotherapy. These results are similar to the PREOPANC-2 trial in BRPC. Since definitions are rarely followed in practice, BRPC and LAPC populations have merged over time; ...

Join for free or sign in to see the full answer